Results 41 to 50 of about 8,135 (150)
Journal of Cutaneous Pathology, Volume 53, Issue 10, Page 887-892, October 2026.ABSTRACT Background Drug‐induced hyperpigmentation accounts for 10%–20% of acquired pigmentary disorders and can be misdiagnosed for other causes such as melasma, post inflammatory changes, or heavy metal deposition. Kratom (Mitragyna speciosa), a Southeast Asian plant with an opioid‐like profile, has been increasingly used in the United States for ...
Rita Kamoua +4 more
wiley +1 more source
BMC Public HealthBackground Adhering to varenicline has been shown to significantly improve the chances of successfully quitting smoking, with studies indicating a twofold increase in 6-month quit rates.
Nadia Minian +9 more
doaj +1 more source
BMC Medicine, 2020 Background Varenicline, bupropion and nicotine replacement therapy (NRT) are three effective pharmacotherapies for smoking cessation, but data about their safety in pregnancy are limited.
Duong Thuy Tran +7 more
doaj +1 more source
CNS Neuroscience &Therapeutics, Volume 32, Issue 9, September 2026.Peripheral nerve injury induces dynamic cortical plasticity, driven by molecular mechanisms such as BDNF and neurotransmitter systems. This review synthesizes subtype‐specific plasticity patterns: compressive injuries trigger rapid reorganization, while metabolic neuropathies lead to maladaptive changes.
Cong Cheng +8 more
wiley +1 more source
Visual hallucinations associated with varenicline: a case report
Journal of Medical Case Reports, 2009 Introduction Varenicline is widely used for smoking cessation. It has shown efficacy over placebo and bupropion in manufacturer-sponsored trials. Those with mental illness were excluded from these trials.
Raidoo B Mahendri, Kutscher Eric C
doaj +1 more source
The Six Pillars of Lifestyle Medicine in MASLD: An Evidence‐Based Guide
Liver International Communications, Volume 7, Issue 3, September 2026.ABSTRACT Metabolic dysfunction–associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide and is projected to affect more than 40% of adults by 2050. Although pharmacologic therapies are emerging, lifestyle modification remains the foundation of management.
Jigyasa Sharma, Kathleen Viveiros
wiley +1 more source
Huli yanjiu, 2015 Objective:To study the effect of 5Aintervention method combined with varenicline for smoking cessation of COPD patients in stable stage.Methods:A total of 300 cases of COPD patients were randomly divided into 5Asmoking cessation group,varenicline group ...
洪涵涵, 王伟, 陈丽调
doaj
Health Technology Assessment, 2014 Background: Tobacco smoking is one of the leading causes of deaths worldwide. Nearly one-fifth of adults in the UK regularly smoke cigarettes. The ill-health associated with smoking costs the NHS over £3B every year.
Joanna Leaviss +7 more
doaj +1 more source
Acta Ophthalmologica, Volume 104, Issue 6, Page e630-e647, September 2026.Abstract Purpose To identify associations between systemic drugs and cataract surgery in Finland. Methods A historic cohort study based on administrative data. Endpoint event was cataract surgery. Use of drugs in question was based on redeemed prescriptions and consisted of 156 drugs.
Antti Riikonen +3 more
wiley +1 more source
Frontiers in Behavioral Neuroscience, 2019 Nicotine is acknowledged as the key addictive compound of tobacco. Varenicline (Champix® or Chantix®), mainly acting as a partial agonist at the α4β2 nicotinic receptor, is an approved smoking cessation pharmacotherapy, although with efficacy limited to ...
Vernon Garcia-Rivas +13 more
doaj +1 more source